Departments of Obstetrics, Gynecology and Reproductive Sciences and Pediatrics, Yale School of Medicine, New Haven Connecticut; the Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, California; the University of Colorado, Denver, School of Medicine, Denver, Colorado; the Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago Illinois; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, Massachusetts; the Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland Oregon; the Fetal Medicine Research Institute, Kings College Hospital, London, United Kingdom; the Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston Texas; the Department Obstetrics, Gynecology and Reproductive Sciences, University of Texas at Houston, Houston, Texas; the Department of Obstetrics and Gynecology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; the Department of Obstetrics and Gynecology, Wright State University, Dayton, Ohio; Women & Infants Hospital, Brown University, Providence, Rhode Island; and the Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Corresponding author: Joshua A. Copel, MD, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT; email: [email protected].
This meeting was sponsored by the Gottesfeld-Hohler Memorial Foundation.
Financial Disclosure Joshua A. Copel disclosed receiving funds from World Class CME, speakers honorarium; Jubel, LLC, no money received, consultant to startup patient information portal; and Nuvo Inc, medical equipment manufacturer, no money paid, medical advisory board. He has received authorship royalties from Elsevier for two textbooks and UptoDate for card authorship. Lawrence D. Platt disclosed that the Gottesfeld-Hohler Memorial Foundation paid for travel and hotel. He is President of the foundation and received no money other than the travel reimbursement and hotel and meals. He received research support from GE Medical Systems and research support from Illumina. Christina S. Han disclosed receiving funds from Roche. Drs. Copel and Han are consultants to Jubel, LLC. Drs. Copel and Platt are consultants to Nuvo, Inc. The other authors did not report any potential conflicts of interest.
This article represents a consensus on risk assessment for early-onset preeclampsia in the United States formulated during a conference held in Ft. Lauderdale, Florida, May 11–12, 2018.
The authors thank Michael Greene, MD, Heather Lipkind, MD, Anthony Odibo, MD, and Joanne Stone, MD for additional contributions during the meeting.
Dr. Chescheir, Editor-in-Chief of Obstetrics & Gynecology, was not involved in the review or decision to publish this article.
Each author has confirmed compliance with the journal's requirements for authorship.
Peer reviews and author correspondence are available at https://links.lww.com/AOG/B601
